Lysosomal Storage Disorders and Parkinson's Disease: New Susceptibility Loci Identified

作者
Diana A. Olszewska,Timothy Lynch
出处
期刊:Movement Disorders Clinical Practice [Wiley]
卷期号:5 (4): 404-405 被引量:1
标识
DOI:10.1002/mdc3.12625
摘要

Robak, LA, Jansen, IE, Rooij, J et al. Excessive burden of lysosomal storage disorder gene variants in Parkinson's disease. Brain. 2017 Dec 1; 140( 12): 3191- 3203. Mutations in the glucocerebrosidase gene (GBA) cause autosomal recessive Gaucher's disease. The connection between the GBA gene and Parkinson's disease (PD) was recently recognized; GBA mutations impair alpha-synuclein clearance,3 and prompt a search for any relationship between PD and other lysosomal disorders (LSDs).1 Mutations in alpha-synuclein, LRRK2, VPS35, PINK1, DJ1 are associated with mitochondrial and endo-lysosomal dysfunction.2 Both mitochondria and lysosomes are involved in lipid and protein trafficking and metabolism.2 Moreover, mutations in LSD genes may lead to PD by altering lysosomal activity resulting in alpha-synuclein accumulation and disrupting the transport of highly specific hydrolases within dopaminergic neurons, thus impairing mitochondrial quality control mechanisms. Homozygous and heterozygous GBA mutations are the largest genetic risk factor for PD (5-20 increased risk).3 While there are multiple studies involving GBA in PD, there are few studies of other lysosomal disorders.1 The small number of studies of other LSDs may be because patients with severe childhood LSDs die before PD symptoms appear, or that once PD is diagnosed metabolic tests are not done, resulting in few patients available for study.4 However, features of parkinsonism occur in some metabolic disorders, including Niemann Pick's disease, lipogranulomatosis, or ceroid lipofuscinosis.4 Robak and colleagues recently assessed the mutation burden of other LSD genes and PD susceptibility by using the largest available whole exome sequencing (WES) database (1156 PD patients and 1679 controls). The results were replicated in two independent cohorts (PPMI and NeuroX) of over 7000 PD patients and more than 6000 controls.1 Fifty-four lysosomal genes were evaluated.1 The authors confirmed the known PD association at the Gaucher's and Niemann Pick's loci. They also showed association of three novel loci including cathepsin D gene (CTSD) associated with ceroid lipofuscinosis (seizures, myoclonus, ataxia, blindness),5 solute carrier family 17 member 5 (SLC17A5) associated with Salla disease (developmental delay, seizures, ataxia, spasticity, athetosis),6 and N-acylsphingosine amidohydrolase (ASAH1) associated with Farber lipogranulomatosis (subcutaneous nodules, deformed joints, hoarseness) with PD.1 Over half of PD patients had at least one mutation in a LSD gene. Roughly one-fifth carried multiple mutations. Thus, the susceptibility to PD increased in the presence of several lysosomal genetic risk factors. Importantly, the association remained significant even following GBA exclusion.1 The three novel risk factors identified by Robak et al. have a role in lysosomal transport (SLC17A5), ceramide metabolism (ASAH1), and in alpha-synuclein degradation (CTSD is a lysosomal proteinase).1 In the near future, we are hopeful that explicit disease-modifying therapies will be developed for specific genetic forms of PD such as LRRK2 kinase inhibitors, knockdown therapy for SNCA duplications, parkin mitochondrial enhancers, or enzymatic compounds capable of crossing brain-blood barrier in GBA carriers (such as over the counter medication for respiratory conditions facilitating lysosomal exocitosis-ambroxol). The additional loci discovered in this study and the identification of an increased burden of lysosomal genetic risk factors in PD may increase our understanding of the interplay between mitochondria and lysosomes (two closely related cell housekeeping regulators), and provide further insight into PD pathogenesis. Thus hopefully leading to the development of innovative precision therapies for PD. 1. Research Project: A. Conception, B. Organization, C. Execution; 2. Statistical Analysis: A. Design, B. Execution, C. Review and Critique; 3. Manuscript Preparation: A. Writing the First Draft, B. Review and Critique. D.A.O.: 3A T.L.: 3B Ethical Compliance Statement: We confirm that we have read the Journal's position on issues involved in ethical publication and affirm that this work is consistent with those guidelines. Funding Sources and Conflict of Interest: No specific funding was received for this work. The authors declare that there are no conflicts of interest relevant to this work. Financial Disclosures for the previous 12 months: The authors declare that there are no additional disclosures to report.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
贪玩丑完成签到,获得积分10
1秒前
yl1111完成签到,获得积分10
2秒前
wdddr发布了新的文献求助20
2秒前
Gustav_Lebon发布了新的文献求助10
2秒前
乐乐的应助被gxy采纳,获得10
2秒前
3秒前
李健的粉丝团团长的应助被Song采纳,获得10
4秒前
榴莲爱美丽完成签到,获得积分10
5秒前
6秒前
英俊的铭的应助被贪玩丑采纳,获得10
6秒前
7秒前
ZZ发布了新的文献求助10
7秒前
小萝卜发布了新的文献求助10
7秒前
8秒前
FashionBoy的应助被ZhouJing采纳,获得10
9秒前
雇凶暗杀蛋饺完成签到,获得积分10
9秒前
经十路以东的应助被tom采纳,获得10
9秒前
丘比特的应助被qqqqqqqqqq采纳,获得10
10秒前
ERCPdoctor发布了新的文献求助100
11秒前
等风的拾荒者完成签到 ,获得积分10
12秒前
魔幻伟宸完成签到,获得积分10
13秒前
carol7298完成签到,获得积分10
13秒前
wellforever发布了新的文献求助10
13秒前
秦知余完成签到,获得积分20
15秒前
16秒前
斯文败类的应助被眼角流星采纳,获得10
17秒前
经十路以东的应助被00hello00采纳,获得10
17秒前
17秒前
火山完成签到,获得积分10
18秒前
19秒前
19秒前
情怀的应助被闪耀的启明星采纳,获得10
19秒前
LYB完成签到 ,获得积分10
19秒前
20秒前
syvshc的应助被00hello00采纳,获得10
20秒前
呆桃完成签到 ,获得积分10
21秒前
王亚娟发布了新的文献求助10
22秒前
kookery完成签到,获得积分10
22秒前
贪玩丑发布了新的文献求助10
22秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8194107
求助须知:如何正确求助?哪些是违规求助? 9580062
关于积分的说明 21869017
捐赠科研通 7793713
什么是DOI,文献DOI怎么找? 3437523
关于科研通互助平台的介绍 2560962
邀请新用户注册赠送积分活动 2484264